business
AU & NZ ENTERPRISE PROFILES

Arovella Therapeutics Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: SUD

What does Arovella Therapeutics Limited do?

Arovella Therapeutics Limited is a locally-owned publicly-traded company, engaged in the development of pharmaceutical treatments, particularly in the oncology and central nervous system areas. The company operates internationally and is administered by its head office in Melbourne Australia.

Arovella Therapeutics is listed on the Australian Securities Exchange under the code ALA.

Arovella Therapeutics Limited - Products & Brands

Arovella TherapeuticsLimted is a pharmaceutical developer focusing on the oncology and central nervous system (CNS) areas. The company is based in Melbourne Victoria, however opperates internationally with patents and contracts with counties such as Japan and the USA.

 

Arovella currently has the following treatment and products under its brand:

  • iNKT Cell Therapy Platform - Supplied by the Imperial College London and used in the treatment of blood cancers
  • DKK1-Car-iNKT
  • CAR19-iNKT + CF33-CD19
  • Anagrelide - Used in the reduction of platelets and lowering of thrombotic risk in myeloproliferative diseases associated with high platelet counts.
  • ZolpiMist - An oral based spray containing zolpidem tartrate used in aiding sleep quality.

 

IBISWorld provides enterprise profiles on thousands of leading organizations across Australia and New Zealand.

LEARN MORE

Arovella Therapeutics Limited - Financial Statements

pie_chart Arovella Therapeutics Limited Financial Profit & Loss Account

BALANCE DATE6/30/20236/30/20226/30/20216/30/20206/30/2019
Sales Revenue4060.00.00.00.0
Other Revenue0000000000000000000000000
Total Revenue0000000000000000000000000
Cost of Goods Sold0000000000000000000000000
Depreciation0000000000000000000000000
R & D Expenditure0000000000000000000000000
lock To view Arovella Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Arovella Therapeutics Limited - Financial Ratios

pie_chart Arovella Therapeutics Limited Financial Growth

BALANCE DATE6/30/20236/30/20226/30/20216/30/20206/30/2019
Total Revenue Growth395.00-74.38-12.083.90160.56
Sales Revenue Growth0000000000000000000000000
EBITDA0000000000000000000000000
NPAT0000000000000000000000000
Shareholder's Funds0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000

pie_chart Arovella Therapeutics Limited Financial Ratios

BALANCE DATE6/30/20236/30/20226/30/20216/30/20206/30/2019
Return on Revenue (ROR) (%)-685.6-2873.7-431.0-745.9-608.0
Return on Shareholders’ Funds (ROSF) (%)0000000000000000000000000
Return on Assets (ROA) (%)0000000000000000000000000
Profit Margin (%)0000000000000000000000000
Revenue per Employee ($’000 per person)0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000
lock To view Arovella Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Arovella Therapeutics Limited's Competitive Environment

Arovella Therapeutics Limited operates in the following industries:

Arovella Therapeutics Limited's main competitors:

  • CSL Limited
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
lock To view Arovella Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Arovella Therapeutics Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Arovella Therapeutics Limited by position type and title.

Enterprise Financials

Get a full view of Arovella Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Arovella Therapeutics Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Arovella Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Arovella Therapeutics Limited operates in.

Competitor Benchmarking

Compare Arovella Therapeutics Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Arovella Therapeutics Limited.

Subsidiaries

View a list of Arovella Therapeutics Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Arovella Therapeutics Limited, including founding information, past announcements, mergers and major projects.

Purchase to Read Full Report

100% Money Back Guarantee Digicert Trusted

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Enterprise Financial Statements
  • Financial Ratios
    Financial Ratios
  • Industry Averages
    Industry Averages
  • Competitive Landscape
    Competitive Landscape
  • Key Enterprise Personnel
    Key Enterprise Personnel
  • Subsidiaries & Ownership Structure
    Subsidiaries & Ownership Structure

Why buy this enterprise profile on Arovella Therapeutics Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on Arovella Therapeutics Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal